data_2hm5_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hm5 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 N--CA 1.464 -0.257 0 CA-C-O 121.546 0.561 . . . . 0.0 112.996 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.0 m -53.5 -45.43 69.66 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.777 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.66 -34.58 21.22 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.38 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.421 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.61 -35.09 67.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.13 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -66.2 -43.91 85.42 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.24 -76.27 1.18 Allowed Glycine 0 C--N 1.317 -0.511 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.426 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -83.91 103.52 13.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.587 0.708 . . . . 0.0 110.16 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 t -77.29 78.84 3.82 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.508 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.2 p90 -72.42 160.58 82.42 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.64 -39.88 74.7 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.664 2.242 . . . . 0.0 115.398 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.45 -7.82 51.83 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.218 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.405 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 90.3 m -67.53 123.48 86.83 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.69 147.17 85.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.072 1.848 . . . . 0.0 112.226 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -37.33 138.97 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.444 2.763 . . . . 0.0 115.068 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.273 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.913 178.451 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 CA-C-O 121.745 0.644 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.4 m -54.22 -47.02 72.63 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.452 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.42 -35.68 21.85 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.464 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.421 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.9 m -72.92 -34.08 66.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.083 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -66.51 -44.64 81.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.71 -74.92 1.23 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.023 -1.085 . . . . 0.0 112.702 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' GLY . 53.9 m-20 -83.59 103.44 12.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.716 0.769 . . . . 0.0 110.068 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.7 79.04 4.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.013 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 p90 -72.24 159.27 85.86 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.174 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.52 -44.06 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.469 2.113 . . . . 0.0 114.593 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.79 -3.8 30.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.367 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 22.4 m -67.08 122.48 82.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.327 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -46.64 162.61 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.938 1.759 . . . . 0.0 112.664 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.45 140.39 52.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.854 2.369 . . . . 0.0 112.877 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.547 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.478 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.463 -0.314 0 CA-C-O 121.743 0.643 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m -54.11 -46.72 72.22 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.549 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.3 -36.86 23.54 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.73 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.416 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.81 -33.19 66.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.107 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -66.26 -46.37 77.3 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.08 -75.29 1.18 Allowed Glycine 0 C--N 1.315 -0.608 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.455 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 11' ' ' GLY . 1.3 m-20 -84.0 103.48 13.28 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.585 0.707 . . . . 0.0 110.518 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 t -77.36 78.65 3.88 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.224 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.8 p90 -72.24 159.94 84.06 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.625 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.51 -43.62 38.23 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.844 2.362 . . . . 0.0 114.934 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -72.92 -5.38 38.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.239 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -67.5 123.56 87.01 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.2 168.69 10.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.95 1.766 . . . . 0.0 112.275 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.46 140.39 81.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.062 2.508 . . . . 0.0 113.75 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.417 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.074 179.572 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo . . . . . 0 N--CA 1.46 -0.497 0 CA-C-O 122.066 0.777 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.2 m -54.83 -48.66 72.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.517 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.58 -37.25 26.23 Favored Glycine 0 CA--C 1.503 -0.714 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.589 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.4 m -72.5 -32.59 66.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.654 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -67.0 -44.99 78.95 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.33 -74.8 1.26 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.088 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 59.6 m-20 -83.7 103.36 12.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.81 0.814 . . . . 0.0 110.035 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.29 78.28 3.82 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.388 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.3 p90 -72.34 159.22 85.96 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.869 -0.733 . . . . 0.0 109.432 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -49.34 -41.99 41.7 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.729 2.286 . . . . 0.0 115.154 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.13 -6.9 48.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.135 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -67.45 123.58 87.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.43 166.28 15.61 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.784 1.656 . . . . 0.0 112.339 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.89 140.18 85.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.889 2.393 . . . . 0.0 114.676 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.245 0 CA-C-N 114.164 -1.38 . . . . 0.0 113.843 178.15 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.463 -0.294 0 CA-C-O 121.477 0.532 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.3 m -53.77 -44.95 70.46 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.986 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.31 -36.07 21.95 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.575 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.8 m -72.78 -33.14 66.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.062 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -66.39 -44.63 82.54 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.87 -76.57 1.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.78 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' GLY . 25.7 m-20 -83.98 103.45 13.24 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 0.0 110.543 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.14 79.81 3.66 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.251 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.7 p90 -72.11 161.33 79.46 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.461 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -50.53 -43.26 45.9 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 114.816 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.02 -6.14 43.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.285 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.46 123.12 85.86 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.106 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.09 172.07 5.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.031 1.821 . . . . 0.0 112.298 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.5 140.12 80.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.14 2.56 . . . . 0.0 114.16 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.457 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.054 179.026 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 121.46 0.525 . . . . 0.0 112.836 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.8 m -53.47 -44.71 69.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.695 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.56 -34.22 19.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.342 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.45 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.76 -34.83 67.27 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -66.01 -47.81 73.23 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.03 -73.92 1.19 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.232 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -84.05 103.28 13.15 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.786 0.803 . . . . 0.0 110.36 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.54 79.42 4.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.609 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.4 p90 -72.66 158.77 86.8 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.049 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.88 -42.04 66.52 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.627 2.218 . . . . 0.0 114.924 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.04 -3.75 31.23 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.323 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 32.1 m -66.95 122.67 83.53 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.451 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.33 163.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.86 1.707 . . . . 0.0 113.033 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.59 140.07 46.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.88 2.387 . . . . 0.0 112.378 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.52 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.55 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.464 -0.207 0 CA-C-O 121.854 0.689 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.4 m -54.63 -52.74 61.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.242 -1.345 . . . . 0.0 112.661 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.84 -37.42 21.5 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.947 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.87 -31.54 64.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.849 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -66.91 -45.55 77.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.4 -75.84 1.23 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.959 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 11' ' ' GLY . 61.7 m-20 -83.92 103.78 13.47 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.739 0.78 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.15 78.76 3.68 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.046 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 3.4 p90 -72.31 159.86 84.29 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.192 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.44 -43.07 39.91 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.557 2.171 . . . . 0.0 114.867 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -73.01 -5.79 41.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.15 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 73.5 m -67.5 122.87 85.06 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.346 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.25 168.86 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 121.677 1.584 . . . . 0.0 112.139 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.56 140.45 87.08 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.175 2.583 . . . . 0.0 114.017 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.385 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.976 179.302 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.462 -0.375 0 CA-C-O 121.382 0.493 . . . . 0.0 112.574 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m -52.98 -43.11 66.16 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.557 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.47 -34.45 19.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.191 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.431 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 2.4 m -72.93 -36.44 67.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.972 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.25 -44.48 83.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.53 -74.87 1.2 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.511 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -83.89 103.42 13.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.672 0.749 . . . . 0.0 110.73 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.41 79.11 3.92 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.111 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.2 p90 -73.02 159.7 84.64 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.27 -40.75 81.09 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 122.635 2.223 . . . . 0.0 115.094 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.15 -3.5 30.09 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.534 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.414 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 47.3 m -66.84 122.19 81.2 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -48.46 141.38 19.61 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.972 1.782 . . . . 0.0 112.995 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -44.77 139.63 7.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.608 2.205 . . . . 0.0 113.512 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.53 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.48 179.186 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.463 -0.311 0 CA-C-O 121.573 0.572 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -53.77 -45.14 70.54 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.979 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.41 -34.72 14.01 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.074 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 2.3 m -72.66 -34.91 67.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.747 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.36 -45.28 80.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.87 -75.14 1.17 Allowed Glycine 0 C--N 1.316 -0.548 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.41 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 11' ' ' GLY . 13.1 m-20 -84.01 103.7 13.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.678 0.752 . . . . 0.0 110.506 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.25 78.59 3.77 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.803 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.0 p90 -72.8 159.15 86.03 Favored Pre-proline 0 N--CA 1.446 -0.65 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.097 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.46 -42.54 60.63 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.654 2.236 . . . . 0.0 115.092 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.73 -3.46 28.55 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.418 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.5 m -67.09 122.69 83.81 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.251 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -46.73 163.94 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.864 1.709 . . . . 0.0 112.893 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.8 139.92 49.32 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.8 2.334 . . . . 0.0 112.533 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.442 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.523 -179.615 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 CA--C 1.528 0.218 0 CA-C-O 121.506 0.544 . . . . 0.0 113.113 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -53.79 -45.4 70.7 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.182 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -48.24 -33.93 11.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.456 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 2.3 m -72.98 -35.17 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 121.311 -0.155 . . . . 0.0 110.82 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -66.19 -46.53 76.98 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.33 -74.37 1.18 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.366 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 11' ' ' GLY . 41.0 m-20 -83.71 103.44 13.01 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.755 0.788 . . . . 0.0 110.378 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.47 78.24 3.98 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.581 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.3 p90 -72.86 159.15 86.01 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.374 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.85 -42.61 62.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.727 2.284 . . . . 0.0 115.025 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -73.86 -2.67 24.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 33.2 m -66.83 122.38 82.07 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.984 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -50.28 139.92 35.02 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.909 1.739 . . . . 0.0 113.131 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -43.94 140.09 5.25 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.01 2.473 . . . . 0.0 114.276 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.583 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.667 178.791 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.607 -0.197 . . . . 0.0 112.607 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.3 m -132.99 -45.88 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -96.21 -25.14 15.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.903 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.56 HG21 ' N ' ' A' ' 5' ' ' THR . 0.2 OUTLIER 41.76 -166.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.56 ' N ' HG21 ' A' ' 4' ' ' ILE . 68.9 p -120.58 138.87 53.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.825 0.345 . . . . 0.0 111.047 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.6 -91.22 0.35 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.86 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.0 m -84.95 -50.29 7.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.219 0.533 . . . . 0.0 111.386 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 35.3 m -72.12 116.08 45.11 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.11 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.28 -176.72 2.31 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.006 1.804 . . . . 0.0 112.996 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.0 m -53.5 -45.43 69.66 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.777 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.66 -34.58 21.22 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.38 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -72.61 -35.09 67.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.13 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -66.2 -43.91 85.42 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.24 -76.27 1.18 Allowed Glycine 0 C--N 1.317 -0.511 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.426 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -83.91 103.52 13.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.587 0.708 . . . . 0.0 110.16 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 t -77.29 78.84 3.82 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.508 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.2 p90 -72.42 160.58 82.42 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.64 -39.88 74.7 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.664 2.242 . . . . 0.0 115.398 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.45 -7.82 51.83 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.218 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.405 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 90.3 m -67.53 123.48 86.83 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.699 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 31.4 Cg_endo -65.69 147.17 85.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.072 1.848 . . . . 0.0 112.226 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -37.33 138.97 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.444 2.763 . . . . 0.0 115.068 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.55 15.84 48.19 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.913 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.699 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.14 -39.63 20.81 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.194 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 6.4 p -88.15 141.73 28.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.865 0.364 . . . . 0.0 110.777 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.05 58.48 7.01 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.822 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.7 4.19 7.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.807 0.337 . . . . 0.0 111.56 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 28' ' ' VAL . 9.2 p -132.11 80.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.6 0.714 . . . . 0.0 111.169 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' C ' ' H ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -156.63 115.56 3.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.416 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.37 26.73 0.13 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.57 0.224 . . . . 0.0 111.496 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.422 ' H ' ' C ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.757 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.78 127.1 30.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.341 . . . . 0.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -161.63 33.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.684 HG22 ' N ' ' A' ' 5' ' ' THR . 37.8 mm -103.29 160.09 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.343 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.684 ' N ' HG22 ' A' ' 4' ' ' ILE . 14.1 p -75.31 -34.72 61.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.511 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -173.06 77.13 0.09 OUTLIER Glycine 0 C--N 1.319 -0.392 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.09 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.473 ' OG1' HG23 ' A' ' 4' ' ' ILE . 63.9 m -85.3 -55.25 4.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.25 0.547 . . . . 0.0 111.208 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.565 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 56.3 m -71.56 126.47 91.64 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.292 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.41 -178.45 1.85 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.077 1.851 . . . . 0.0 113.347 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.4 m -54.22 -47.02 72.63 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.452 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.42 -35.68 21.85 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.464 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.551 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.9 m -72.92 -34.08 66.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.083 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -66.51 -44.64 81.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.71 -74.92 1.23 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.023 -1.085 . . . . 0.0 112.702 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' GLY . 53.9 m-20 -83.59 103.44 12.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.716 0.769 . . . . 0.0 110.068 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.7 79.04 4.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.013 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 p90 -72.24 159.27 85.86 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.174 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.52 -44.06 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.469 2.113 . . . . 0.0 114.593 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.79 -3.8 30.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.367 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 22.4 m -67.08 122.48 82.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.327 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HD2' ' SG ' ' A' ' 8' ' ' CYS . 87.4 Cg_exo -46.64 162.61 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.938 1.759 . . . . 0.0 112.664 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.45 140.39 52.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.854 2.369 . . . . 0.0 112.877 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.85 16.11 50.81 Favored Glycine 0 C--N 1.316 -0.547 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.478 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.58 -38.72 21.28 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.43 178.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 9.6 p -88.79 143.66 26.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.018 0.437 . . . . 0.0 111.35 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.92 65.5 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.619 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -73.17 0.49 11.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.507 HG11 ' O ' ' A' ' 28' ' ' VAL . 8.2 p -123.19 76.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.608 0.718 . . . . 0.0 111.18 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -166.5 151.65 8.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.533 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.595 ' H ' HD12 ' A' ' 30' ' ' LEU . 1.7 mp -92.33 34.73 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.559 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.783 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.9 -44.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 110.905 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . 0.409 ' C ' HD12 ' A' ' 4' ' ' ILE . 32.3 tt0 -165.86 -22.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.407 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.56 ' N ' HD12 ' A' ' 4' ' ' ILE . 2.4 mm -93.03 37.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.964 0.888 . . . . 0.0 110.483 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -136.43 -176.84 4.47 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.692 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.49 -91.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.104 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.2 m -154.97 -61.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.066 0.46 . . . . 0.0 111.329 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.484 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 91.0 m -70.96 122.93 88.36 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.395 -175.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.3 -178.83 2.75 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.992 1.795 . . . . 0.0 113.499 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m -54.11 -46.72 72.22 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.549 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.3 -36.86 23.54 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.73 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.529 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -72.81 -33.19 66.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.107 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.54 ' HB3' ' HG2' ' A' ' 27' ' ' GLN . 7.4 m -66.26 -46.37 77.3 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.08 -75.29 1.18 Allowed Glycine 0 C--N 1.315 -0.608 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.455 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 11' ' ' GLY . 1.3 m-20 -84.0 103.48 13.28 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.585 0.707 . . . . 0.0 110.518 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 t -77.36 78.65 3.88 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.224 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.8 p90 -72.24 159.94 84.06 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.625 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.51 -43.62 38.23 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.844 2.362 . . . . 0.0 114.934 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -72.92 -5.38 38.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.239 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -67.5 123.56 87.01 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.697 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 19.2 Cg_endo -63.2 168.69 10.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.95 1.766 . . . . 0.0 112.275 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.46 140.39 81.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.062 2.508 . . . . 0.0 113.75 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.25 14.35 53.31 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.074 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.697 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.32 -44.16 15.2 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.48 178.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 18.6 p -88.4 146.95 24.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.023 0.44 . . . . 0.0 111.42 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.17 71.6 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.399 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.54 ' HG2' ' HB3' ' A' ' 13' ' ' SER . 1.0 OUTLIER -106.94 0.14 23.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 111.385 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.414 ' O ' HG12 ' A' ' 28' ' ' VAL . 14.2 p -91.28 65.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.795 0.807 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -166.77 95.21 0.51 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.654 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.17 -58.9 3.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.964 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.942 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.566 -0.213 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.5 p -74.12 96.81 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.816 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -157.35 152.1 25.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.802 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.477 HG21 ' N ' ' A' ' 5' ' ' THR . 0.2 OUTLIER 44.51 -173.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.235 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.477 ' N ' HG21 ' A' ' 4' ' ' ILE . 12.6 t -154.99 -164.06 1.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.526 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.67 -89.94 0.13 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.186 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.451 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 52.4 m -155.38 -71.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.15 0.5 . . . . 0.0 110.347 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 81.4 m -71.91 108.64 4.33 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.508 -177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 7' ' ' THR . 14.6 Cg_exo -60.11 -173.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.981 1.788 . . . . 0.0 112.817 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.2 m -54.83 -48.66 72.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.517 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.58 -37.25 26.23 Favored Glycine 0 CA--C 1.503 -0.714 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.589 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.4 m -72.5 -32.59 66.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.654 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -67.0 -44.99 78.95 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.33 -74.8 1.26 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.088 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 59.6 m-20 -83.7 103.36 12.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.81 0.814 . . . . 0.0 110.035 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.29 78.28 3.82 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.388 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.3 p90 -72.34 159.22 85.96 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.869 -0.733 . . . . 0.0 109.432 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -49.34 -41.99 41.7 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.729 2.286 . . . . 0.0 115.154 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.13 -6.9 48.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.135 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -67.45 123.58 87.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.517 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 19.9 Cg_endo -63.43 166.28 15.61 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.784 1.656 . . . . 0.0 112.339 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.89 140.18 85.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.889 2.393 . . . . 0.0 114.676 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.93 16.55 52.63 Favored Glycine 0 C--N 1.322 -0.245 0 CA-C-N 114.164 -1.38 . . . . 0.0 113.843 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.517 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.09 -40.39 19.9 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.442 178.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 4.2 p -88.2 141.77 28.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.889 0.376 . . . . 0.0 110.877 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 27' ' ' GLN . . . 160.79 -62.98 0.29 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.547 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 26' ' ' GLY . 5.4 pt20 54.49 10.23 0.32 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.5 t 61.51 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.536 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 71.75 119.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.057 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -122.97 -76.55 0.59 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.937 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.904 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 p -72.08 116.73 12.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.859 0.361 . . . . 0.0 110.824 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -139.44 -18.11 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.34 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -104.73 -32.94 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -159.32 169.84 23.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.915 0.388 . . . . 0.0 111.187 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.27 91.52 2.22 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.727 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.5 m -155.36 -79.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 110.573 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.551 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 74.1 m -72.21 118.16 64.8 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.41 -176.77 2.08 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.069 1.846 . . . . 0.0 112.65 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.3 m -53.77 -44.95 70.46 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.986 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.31 -36.07 21.95 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.575 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.8 m -72.78 -33.14 66.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.062 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -66.39 -44.63 82.54 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.87 -76.57 1.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.78 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' GLY . 25.7 m-20 -83.98 103.45 13.24 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 0.0 110.543 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.14 79.81 3.66 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.251 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.7 p90 -72.11 161.33 79.46 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.461 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -50.53 -43.26 45.9 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 114.816 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.02 -6.14 43.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.285 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.46 123.12 85.86 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.106 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.613 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 18.6 Cg_endo -63.09 172.07 5.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.031 1.821 . . . . 0.0 112.298 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.5 140.12 80.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.14 2.56 . . . . 0.0 114.16 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.02 15.74 50.65 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.054 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.613 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.01 -43.72 16.03 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.113 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 7.8 p -88.34 148.59 24.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.891 0.377 . . . . 0.0 110.934 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.649 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . 142.68 -64.16 0.5 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.441 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.649 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER 50.63 11.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 28' ' ' VAL . 8.5 p -128.97 78.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.46 0.648 . . . . 0.0 111.064 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.33 57.66 1.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.228 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.2 tp -167.46 92.2 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.7 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 CA-C-O 120.388 -0.118 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 66.59 119.4 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.945 0.372 . . . . 0.0 110.517 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -137.54 111.64 8.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.111 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.403 ' CD1' ' N ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -137.1 -46.18 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.384 0.611 . . . . 0.0 109.418 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.16 161.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.233 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.61 -72.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.139 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.9 m -155.83 -86.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.501 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 10.4 m -73.07 112.16 14.43 Favored Pre-proline 0 N--CA 1.447 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.418 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.57 -178.13 3.53 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.72 1.613 . . . . 0.0 112.836 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.8 m -53.47 -44.71 69.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.695 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.56 -34.22 19.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.342 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 1.7 m -72.76 -34.83 67.27 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.821 ' HB3' ' HA ' ' A' ' 28' ' ' VAL . 50.8 m -66.01 -47.81 73.23 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.03 -73.92 1.19 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.232 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -84.05 103.28 13.15 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.786 0.803 . . . . 0.0 110.36 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.54 79.42 4.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.609 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.4 p90 -72.66 158.77 86.8 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.049 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.88 -42.04 66.52 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.627 2.218 . . . . 0.0 114.924 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.04 -3.75 31.23 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.323 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 32.1 m -66.95 122.67 83.53 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.451 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 81.4 Cg_exo -45.33 163.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.86 1.707 . . . . 0.0 113.033 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.59 140.07 46.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.88 2.387 . . . . 0.0 112.378 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.75 14.06 27.84 Favored Glycine 0 C--N 1.317 -0.52 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.55 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -41.51 17.94 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.826 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 31.2 p -88.92 146.89 24.64 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.901 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 -64.43 0.45 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.984 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -52.15 -27.45 14.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.206 0.526 . . . . 0.0 111.729 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.821 ' HA ' ' HB3' ' A' ' 13' ' ' SER . 7.1 p 35.48 89.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.524 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -145.49 155.39 43.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.972 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.77 52.18 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.416 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.747 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.8 p -153.52 -23.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.649 0.262 . . . . 0.0 111.2 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.88 -25.1 1.11 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.119 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.723 HG13 ' H ' ' A' ' 5' ' ' THR . 8.5 tp -54.98 -178.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.648 0.379 . . . . 0.0 111.17 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.723 ' H ' HG13 ' A' ' 4' ' ' ILE . 9.9 p -71.81 -34.41 69.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.297 0.57 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 130.32 -66.06 0.58 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.832 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 m -85.5 -68.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.369 . . . . 0.0 111.53 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.539 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 63.1 m -72.31 141.92 83.92 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.23 -179.19 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.083 1.855 . . . . 0.0 113.099 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.4 m -54.63 -52.74 61.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.242 -1.345 . . . . 0.0 112.661 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.84 -37.42 21.5 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.947 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.556 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -72.87 -31.54 64.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.849 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.411 ' OG ' HD11 ' A' ' 4' ' ' ILE . 6.6 m -66.91 -45.55 77.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.4 -75.84 1.23 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.959 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 11' ' ' GLY . 61.7 m-20 -83.92 103.78 13.47 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.739 0.78 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.15 78.76 3.68 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.046 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 3.4 p90 -72.31 159.86 84.29 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.192 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.44 -43.07 39.91 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.557 2.171 . . . . 0.0 114.867 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -73.01 -5.79 41.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.15 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 73.5 m -67.5 122.87 85.06 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.346 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.719 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 10.1 Cg_endo -60.25 168.86 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 121.677 1.584 . . . . 0.0 112.139 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.56 140.45 87.08 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.175 2.583 . . . . 0.0 114.017 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.71 17.35 53.94 Favored Glycine 0 C--N 1.319 -0.385 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.976 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.719 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -83.33 -41.77 17.85 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.879 179.328 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.556 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 4.6 p -88.16 140.73 29.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.071 0.463 . . . . 0.0 111.37 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.5 65.41 0.19 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.105 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 1.7 pt20 -68.69 -4.49 15.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 37.6 t -136.28 81.75 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.162 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -72.61 141.15 48.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.2 mp -99.4 35.96 1.85 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.74 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.033 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.28 116.81 29.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 0.0 110.936 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -139.7 152.66 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.759 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -98.46 -33.31 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.809 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.83 153.87 17.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.19 -102.34 2.46 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.689 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.453 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 88.2 m -84.38 -49.4 8.74 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 9.8 m -73.51 108.93 5.43 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.797 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 7' ' ' THR . 57.1 Cg_endo -76.35 -176.75 3.25 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.807 1.671 . . . . 0.0 112.574 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m -52.98 -43.11 66.16 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.557 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.47 -34.45 19.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.191 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.507 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 2.4 m -72.93 -36.44 67.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.972 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.25 -44.48 83.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.53 -74.87 1.2 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.511 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -83.89 103.42 13.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.672 0.749 . . . . 0.0 110.73 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.41 79.11 3.92 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.111 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.2 p90 -73.02 159.7 84.64 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.27 -40.75 81.09 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 122.635 2.223 . . . . 0.0 115.094 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.15 -3.5 30.09 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.534 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.414 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 47.3 m -66.84 122.19 81.2 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.783 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 86.4 Cg_exo -48.46 141.38 19.61 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.972 1.782 . . . . 0.0 112.995 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -44.77 139.63 7.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.608 2.205 . . . . 0.0 113.512 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.61 14.36 35.48 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.48 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.783 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.36 -40.34 19.54 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.397 178.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 30.3 p -88.68 145.33 25.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.07 0.462 . . . . 0.0 111.217 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.74 63.5 0.28 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.967 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -0.15 7.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.887 0.375 . . . . 0.0 111.77 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 28' ' ' VAL . 11.3 p -99.58 67.84 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.652 0.739 . . . . 0.0 110.981 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' ND2' ' HB2' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -174.0 146.47 1.19 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.555 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.26 40.16 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.036 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.402 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 8.4 t30 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.852 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.4 p -160.34 159.45 31.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 110.836 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -119.27 78.65 1.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.709 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.465 HG13 ' H ' ' A' ' 5' ' ' THR . 1.4 pt -62.06 -39.59 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.257 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.465 ' H ' HG13 ' A' ' 4' ' ' ILE . 29.0 p -102.72 -59.19 1.75 Allowed 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.311 0.577 . . . . 0.0 111.11 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.3 76.55 0.23 Allowed Glycine 0 C--N 1.316 -0.532 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.471 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.3 m -84.85 -48.2 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.255 0.55 . . . . 0.0 111.107 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 10.6 m -72.47 113.13 18.25 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.359 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.01 -178.45 3.87 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.823 1.682 . . . . 0.0 113.164 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -53.77 -45.14 70.54 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.979 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.41 -34.72 14.01 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.074 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 2.3 m -72.66 -34.91 67.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.747 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.36 -45.28 80.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.87 -75.14 1.17 Allowed Glycine 0 C--N 1.316 -0.548 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.41 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 11' ' ' GLY . 13.1 m-20 -84.01 103.7 13.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.678 0.752 . . . . 0.0 110.506 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.25 78.59 3.77 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.803 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.0 p90 -72.8 159.15 86.03 Favored Pre-proline 0 N--CA 1.446 -0.65 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.097 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.46 -42.54 60.63 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.654 2.236 . . . . 0.0 115.092 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.73 -3.46 28.55 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.418 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.5 m -67.09 122.69 83.81 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.251 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.52 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 94.1 Cg_exo -46.73 163.94 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.864 1.709 . . . . 0.0 112.893 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.8 139.92 49.32 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.8 2.334 . . . . 0.0 112.533 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.59 14.2 27.39 Favored Glycine 0 C--N 1.318 -0.442 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.523 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -40.81 18.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.694 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 29.8 p -88.93 147.04 24.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.979 0.419 . . . . 0.0 110.981 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.56 61.23 5.5 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.395 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.72 94.08 3.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.644 0.735 . . . . 0.0 110.575 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.3 t 46.8 90.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.496 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.26 105.0 5.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.632 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 mt -141.88 -77.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.074 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 t30 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.915 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.58 37.64 4.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.905 0.383 . . . . 0.0 110.756 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.23 144.6 24.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 tp -53.55 154.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.685 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.422 ' O ' HG22 ' A' ' 5' ' ' THR . 0.7 OUTLIER -122.45 -17.77 6.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.401 -179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.23 -77.9 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.105 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 81.4 m -155.55 -87.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.481 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 31.9 m -72.31 114.9 33.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.7 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.0 -179.69 5.24 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.844 1.696 . . . . 0.0 113.113 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -53.79 -45.4 70.7 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.182 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -48.24 -33.93 11.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 2.3 m -72.98 -35.17 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 121.311 -0.155 . . . . 0.0 110.82 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -66.19 -46.53 76.98 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.33 -74.37 1.18 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.366 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 11' ' ' GLY . 41.0 m-20 -83.71 103.44 13.01 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.755 0.788 . . . . 0.0 110.378 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.47 78.24 3.98 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.581 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.3 p90 -72.86 159.15 86.01 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.374 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.85 -42.61 62.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.727 2.284 . . . . 0.0 115.025 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -73.86 -2.67 24.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 33.2 m -66.83 122.38 82.07 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.984 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.765 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 83.6 Cg_exo -50.28 139.92 35.02 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.909 1.739 . . . . 0.0 113.131 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -43.94 140.09 5.25 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.01 2.473 . . . . 0.0 114.276 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.45 14.36 41.43 Favored Glycine 0 N--CA 1.465 0.583 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.667 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.765 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -84.11 -39.98 18.83 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.862 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 27.9 p -89.53 149.75 22.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.067 0.461 . . . . 0.0 111.881 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.67 69.05 1.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.267 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.556 ' O ' HG22 ' A' ' 28' ' ' VAL . 18.7 pm0 -118.44 -24.36 6.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.35 . . . . 0.0 111.412 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 27' ' ' GLN . 23.1 t -149.99 89.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.009 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 58.53 91.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 111.019 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.1 tp -83.46 -59.38 2.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.926 -179.909 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 N--CA 1.464 -0.257 0 CA-C-O 121.546 0.561 . . . . 0.0 112.996 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.0 m -53.5 -45.43 69.66 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.777 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.66 -34.58 21.22 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.38 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.421 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.61 -35.09 67.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.13 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -66.2 -43.91 85.42 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.24 -76.27 1.18 Allowed Glycine 0 C--N 1.317 -0.511 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.426 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -83.91 103.52 13.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.587 0.708 . . . . 0.0 110.16 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 t -77.29 78.84 3.82 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.508 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.2 p90 -72.42 160.58 82.42 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.64 -39.88 74.7 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.664 2.242 . . . . 0.0 115.398 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.45 -7.82 51.83 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.218 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.405 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 90.3 m -67.53 123.48 86.83 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.69 147.17 85.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.072 1.848 . . . . 0.0 112.226 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -37.33 138.97 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.444 2.763 . . . . 0.0 115.068 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.273 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.913 178.451 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 CA-C-O 121.745 0.644 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.4 m -54.22 -47.02 72.63 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.452 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.42 -35.68 21.85 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.464 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.421 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.9 m -72.92 -34.08 66.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.083 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -66.51 -44.64 81.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.71 -74.92 1.23 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.023 -1.085 . . . . 0.0 112.702 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' GLY . 53.9 m-20 -83.59 103.44 12.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.716 0.769 . . . . 0.0 110.068 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.7 79.04 4.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.013 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 p90 -72.24 159.27 85.86 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.174 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.52 -44.06 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.469 2.113 . . . . 0.0 114.593 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.79 -3.8 30.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.367 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 22.4 m -67.08 122.48 82.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.327 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -46.64 162.61 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.938 1.759 . . . . 0.0 112.664 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.45 140.39 52.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.854 2.369 . . . . 0.0 112.877 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.547 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.478 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.463 -0.314 0 CA-C-O 121.743 0.643 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m -54.11 -46.72 72.22 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.549 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.3 -36.86 23.54 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.73 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.416 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.81 -33.19 66.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.107 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -66.26 -46.37 77.3 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.08 -75.29 1.18 Allowed Glycine 0 C--N 1.315 -0.608 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.455 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 11' ' ' GLY . 1.3 m-20 -84.0 103.48 13.28 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.585 0.707 . . . . 0.0 110.518 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 t -77.36 78.65 3.88 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.224 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.8 p90 -72.24 159.94 84.06 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.625 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.51 -43.62 38.23 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.844 2.362 . . . . 0.0 114.934 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -72.92 -5.38 38.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.239 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -67.5 123.56 87.01 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.2 168.69 10.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.95 1.766 . . . . 0.0 112.275 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.46 140.39 81.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.062 2.508 . . . . 0.0 113.75 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.417 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.074 179.572 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo . . . . . 0 N--CA 1.46 -0.497 0 CA-C-O 122.066 0.777 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.2 m -54.83 -48.66 72.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.517 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.58 -37.25 26.23 Favored Glycine 0 CA--C 1.503 -0.714 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.589 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.4 m -72.5 -32.59 66.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.654 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -67.0 -44.99 78.95 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.33 -74.8 1.26 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.088 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 59.6 m-20 -83.7 103.36 12.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.81 0.814 . . . . 0.0 110.035 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.29 78.28 3.82 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.388 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.3 p90 -72.34 159.22 85.96 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.869 -0.733 . . . . 0.0 109.432 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -49.34 -41.99 41.7 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.729 2.286 . . . . 0.0 115.154 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.13 -6.9 48.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.135 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -67.45 123.58 87.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.43 166.28 15.61 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.784 1.656 . . . . 0.0 112.339 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.89 140.18 85.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.889 2.393 . . . . 0.0 114.676 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.245 0 CA-C-N 114.164 -1.38 . . . . 0.0 113.843 178.15 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.463 -0.294 0 CA-C-O 121.477 0.532 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.3 m -53.77 -44.95 70.46 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.986 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.31 -36.07 21.95 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.575 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.8 m -72.78 -33.14 66.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.062 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -66.39 -44.63 82.54 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.87 -76.57 1.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.78 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' GLY . 25.7 m-20 -83.98 103.45 13.24 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 0.0 110.543 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.14 79.81 3.66 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.251 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.7 p90 -72.11 161.33 79.46 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.461 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -50.53 -43.26 45.9 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 114.816 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.02 -6.14 43.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.285 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.46 123.12 85.86 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.106 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.09 172.07 5.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.031 1.821 . . . . 0.0 112.298 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.5 140.12 80.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.14 2.56 . . . . 0.0 114.16 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.457 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.054 179.026 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 121.46 0.525 . . . . 0.0 112.836 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.8 m -53.47 -44.71 69.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.695 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.56 -34.22 19.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.342 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.45 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.76 -34.83 67.27 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -66.01 -47.81 73.23 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.03 -73.92 1.19 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.232 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -84.05 103.28 13.15 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.786 0.803 . . . . 0.0 110.36 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.54 79.42 4.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.609 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.4 p90 -72.66 158.77 86.8 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.049 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.88 -42.04 66.52 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.627 2.218 . . . . 0.0 114.924 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.04 -3.75 31.23 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.323 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 32.1 m -66.95 122.67 83.53 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.451 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.33 163.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.86 1.707 . . . . 0.0 113.033 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.59 140.07 46.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.88 2.387 . . . . 0.0 112.378 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.52 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.55 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.464 -0.207 0 CA-C-O 121.854 0.689 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.4 m -54.63 -52.74 61.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.242 -1.345 . . . . 0.0 112.661 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.84 -37.42 21.5 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.947 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.87 -31.54 64.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.849 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -66.91 -45.55 77.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.4 -75.84 1.23 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.959 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 11' ' ' GLY . 61.7 m-20 -83.92 103.78 13.47 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.739 0.78 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.15 78.76 3.68 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.046 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 3.4 p90 -72.31 159.86 84.29 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.192 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.44 -43.07 39.91 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.557 2.171 . . . . 0.0 114.867 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -73.01 -5.79 41.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.15 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 73.5 m -67.5 122.87 85.06 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.346 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.25 168.86 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 121.677 1.584 . . . . 0.0 112.139 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.56 140.45 87.08 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.175 2.583 . . . . 0.0 114.017 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.385 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.976 179.302 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.462 -0.375 0 CA-C-O 121.382 0.493 . . . . 0.0 112.574 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m -52.98 -43.11 66.16 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.557 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.47 -34.45 19.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.191 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.431 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 2.4 m -72.93 -36.44 67.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.972 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.25 -44.48 83.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.53 -74.87 1.2 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.511 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -83.89 103.42 13.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.672 0.749 . . . . 0.0 110.73 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.41 79.11 3.92 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.111 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.2 p90 -73.02 159.7 84.64 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.27 -40.75 81.09 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 122.635 2.223 . . . . 0.0 115.094 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.15 -3.5 30.09 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.534 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.414 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 47.3 m -66.84 122.19 81.2 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -48.46 141.38 19.61 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.972 1.782 . . . . 0.0 112.995 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -44.77 139.63 7.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.608 2.205 . . . . 0.0 113.512 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.53 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.48 179.186 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.463 -0.311 0 CA-C-O 121.573 0.572 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -53.77 -45.14 70.54 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.979 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.41 -34.72 14.01 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.074 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 2.3 m -72.66 -34.91 67.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.747 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.36 -45.28 80.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.87 -75.14 1.17 Allowed Glycine 0 C--N 1.316 -0.548 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.41 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 11' ' ' GLY . 13.1 m-20 -84.01 103.7 13.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.678 0.752 . . . . 0.0 110.506 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.25 78.59 3.77 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.803 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.0 p90 -72.8 159.15 86.03 Favored Pre-proline 0 N--CA 1.446 -0.65 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.097 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.46 -42.54 60.63 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.654 2.236 . . . . 0.0 115.092 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.73 -3.46 28.55 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.418 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.5 m -67.09 122.69 83.81 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.251 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -46.73 163.94 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.864 1.709 . . . . 0.0 112.893 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.8 139.92 49.32 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.8 2.334 . . . . 0.0 112.533 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.442 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.523 -179.615 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 CA--C 1.528 0.218 0 CA-C-O 121.506 0.544 . . . . 0.0 113.113 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -53.79 -45.4 70.7 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.182 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -48.24 -33.93 11.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.456 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 2.3 m -72.98 -35.17 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 121.311 -0.155 . . . . 0.0 110.82 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -66.19 -46.53 76.98 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.33 -74.37 1.18 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.366 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 11' ' ' GLY . 41.0 m-20 -83.71 103.44 13.01 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.755 0.788 . . . . 0.0 110.378 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.47 78.24 3.98 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.581 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.3 p90 -72.86 159.15 86.01 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.374 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.85 -42.61 62.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.727 2.284 . . . . 0.0 115.025 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -73.86 -2.67 24.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 33.2 m -66.83 122.38 82.07 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.984 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -50.28 139.92 35.02 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.909 1.739 . . . . 0.0 113.131 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -43.94 140.09 5.25 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.01 2.473 . . . . 0.0 114.276 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.583 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.667 178.791 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.607 -0.197 . . . . 0.0 112.607 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.3 m -132.99 -45.88 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -96.21 -25.14 15.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.903 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 5' ' ' THR . 0.2 OUTLIER 41.76 -166.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.568 ' N ' HG23 ' A' ' 4' ' ' ILE . 68.9 p -120.58 138.87 53.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.825 0.345 . . . . 0.0 111.047 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.6 -91.22 0.35 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.86 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.0 m -84.95 -50.29 7.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.219 0.533 . . . . 0.0 111.386 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.575 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 35.3 m -72.12 116.08 45.11 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.11 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.28 -176.72 2.31 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.006 1.804 . . . . 0.0 112.996 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.0 m -53.5 -45.43 69.66 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.777 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.66 -34.58 21.22 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.38 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -72.61 -35.09 67.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.13 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -66.2 -43.91 85.42 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.24 -76.27 1.18 Allowed Glycine 0 C--N 1.317 -0.511 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.426 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -83.91 103.52 13.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.587 0.708 . . . . 0.0 110.16 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 t -77.29 78.84 3.82 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.508 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.2 p90 -72.42 160.58 82.42 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.64 -39.88 74.7 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.664 2.242 . . . . 0.0 115.398 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.45 -7.82 51.83 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.218 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.405 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 90.3 m -67.53 123.48 86.83 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.708 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 31.4 Cg_endo -65.69 147.17 85.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.072 1.848 . . . . 0.0 112.226 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -37.33 138.97 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.444 2.763 . . . . 0.0 115.068 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.55 15.84 48.19 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.913 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.708 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.14 -39.63 20.81 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.194 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 6.4 p -88.15 141.73 28.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.865 0.364 . . . . 0.0 110.777 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.05 58.48 7.01 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.822 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.7 4.19 7.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.807 0.337 . . . . 0.0 111.56 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 28' ' ' VAL . 9.2 p -132.11 80.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.6 0.714 . . . . 0.0 111.169 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.406 ' C ' ' H ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -156.63 115.56 3.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.416 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.37 26.73 0.13 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.57 0.224 . . . . 0.0 111.496 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.757 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.78 127.1 30.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.341 . . . . 0.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -161.63 33.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 6' ' ' GLY . 37.8 mm -103.29 160.09 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.343 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 4' ' ' ILE . 14.1 p -75.31 -34.72 61.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.511 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.608 ' H ' HG22 ' A' ' 4' ' ' ILE . . . -173.06 77.13 0.09 OUTLIER Glycine 0 C--N 1.319 -0.392 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.09 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.511 ' OG1' HG21 ' A' ' 4' ' ' ILE . 63.9 m -85.3 -55.25 4.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.25 0.547 . . . . 0.0 111.208 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.565 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 56.3 m -71.56 126.47 91.64 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.292 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.41 -178.45 1.85 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.077 1.851 . . . . 0.0 113.347 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.4 m -54.22 -47.02 72.63 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.452 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.42 -35.68 21.85 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.464 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.9 m -72.92 -34.08 66.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.083 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -66.51 -44.64 81.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.71 -74.92 1.23 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.023 -1.085 . . . . 0.0 112.702 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' GLY . 53.9 m-20 -83.59 103.44 12.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.716 0.769 . . . . 0.0 110.068 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.7 79.04 4.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.013 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 p90 -72.24 159.27 85.86 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.174 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.52 -44.06 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.469 2.113 . . . . 0.0 114.593 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.79 -3.8 30.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.367 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 22.4 m -67.08 122.48 82.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.327 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HD2' ' SG ' ' A' ' 8' ' ' CYS . 87.4 Cg_exo -46.64 162.61 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.938 1.759 . . . . 0.0 112.664 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.45 140.39 52.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.854 2.369 . . . . 0.0 112.877 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.85 16.11 50.81 Favored Glycine 0 C--N 1.316 -0.547 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.478 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.58 -38.72 21.28 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.43 178.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 9.6 p -88.79 143.66 26.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.018 0.437 . . . . 0.0 111.35 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.92 65.5 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.619 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -73.17 0.49 11.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 28' ' ' VAL . 8.2 p -123.19 76.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.608 0.718 . . . . 0.0 111.18 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -166.5 151.65 8.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.533 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 30' ' ' LEU . 1.7 mp -92.33 34.73 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.559 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.783 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.9 -44.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 110.905 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' C ' HD13 ' A' ' 4' ' ' ILE . 32.3 tt0 -165.86 -22.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.407 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.605 ' N ' HD13 ' A' ' 4' ' ' ILE . 2.4 mm -93.03 37.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.964 0.888 . . . . 0.0 110.483 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -136.43 -176.84 4.47 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.692 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.49 -91.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.104 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.2 m -154.97 -61.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.066 0.46 . . . . 0.0 111.329 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 91.0 m -70.96 122.93 88.36 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.395 -175.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.3 -178.83 2.75 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.992 1.795 . . . . 0.0 113.499 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m -54.11 -46.72 72.22 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.549 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.3 -36.86 23.54 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.73 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.552 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -72.81 -33.19 66.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.107 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.567 ' HB3' ' HG2' ' A' ' 27' ' ' GLN . 7.4 m -66.26 -46.37 77.3 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.08 -75.29 1.18 Allowed Glycine 0 C--N 1.315 -0.608 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.455 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 11' ' ' GLY . 1.3 m-20 -84.0 103.48 13.28 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.585 0.707 . . . . 0.0 110.518 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 t -77.36 78.65 3.88 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.224 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.8 p90 -72.24 159.94 84.06 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.625 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.51 -43.62 38.23 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.844 2.362 . . . . 0.0 114.934 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -72.92 -5.38 38.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.239 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -67.5 123.56 87.01 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.72 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 19.2 Cg_endo -63.2 168.69 10.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.95 1.766 . . . . 0.0 112.275 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.46 140.39 81.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.062 2.508 . . . . 0.0 113.75 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.25 14.35 53.31 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.074 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.72 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.32 -44.16 15.2 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.48 178.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 18.6 p -88.4 146.95 24.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.023 0.44 . . . . 0.0 111.42 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.17 71.6 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.399 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.567 ' HG2' ' HB3' ' A' ' 13' ' ' SER . 1.0 OUTLIER -106.94 0.14 23.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 111.385 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.2 p -91.28 65.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.795 0.807 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -166.77 95.21 0.51 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.654 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.17 -58.9 3.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.964 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.942 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.566 -0.213 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.5 p -74.12 96.81 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.816 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -157.35 152.1 25.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.802 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 5' ' ' THR . 0.2 OUTLIER 44.51 -173.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.235 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.487 ' N ' HG23 ' A' ' 4' ' ' ILE . 12.6 t -154.99 -164.06 1.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.526 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.67 -89.94 0.13 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.186 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.457 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 52.4 m -155.38 -71.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.15 0.5 . . . . 0.0 110.347 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 81.4 m -71.91 108.64 4.33 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.508 -177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 7' ' ' THR . 14.6 Cg_exo -60.11 -173.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.981 1.788 . . . . 0.0 112.817 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.2 m -54.83 -48.66 72.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.517 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.58 -37.25 26.23 Favored Glycine 0 CA--C 1.503 -0.714 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.589 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.4 m -72.5 -32.59 66.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.654 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -67.0 -44.99 78.95 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.33 -74.8 1.26 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.088 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 59.6 m-20 -83.7 103.36 12.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.81 0.814 . . . . 0.0 110.035 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.29 78.28 3.82 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.388 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.3 p90 -72.34 159.22 85.96 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.869 -0.733 . . . . 0.0 109.432 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -49.34 -41.99 41.7 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.729 2.286 . . . . 0.0 115.154 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.13 -6.9 48.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.135 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -67.45 123.58 87.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.537 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 19.9 Cg_endo -63.43 166.28 15.61 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.784 1.656 . . . . 0.0 112.339 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.89 140.18 85.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.889 2.393 . . . . 0.0 114.676 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.93 16.55 52.63 Favored Glycine 0 C--N 1.322 -0.245 0 CA-C-N 114.164 -1.38 . . . . 0.0 113.843 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.09 -40.39 19.9 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.442 178.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 4.2 p -88.2 141.77 28.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.889 0.376 . . . . 0.0 110.877 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 27' ' ' GLN . . . 160.79 -62.98 0.29 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.547 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 26' ' ' GLY . 5.4 pt20 54.49 10.23 0.32 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.5 t 61.51 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.536 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 71.75 119.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.057 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HG ' HE21 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -122.97 -76.55 0.59 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.937 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.904 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 p -72.08 116.73 12.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.859 0.361 . . . . 0.0 110.824 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -139.44 -18.11 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.34 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -104.73 -32.94 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -159.32 169.84 23.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.915 0.388 . . . . 0.0 111.187 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.27 91.52 2.22 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.727 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.5 m -155.36 -79.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 110.573 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.558 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 74.1 m -72.21 118.16 64.8 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.41 -176.77 2.08 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.069 1.846 . . . . 0.0 112.65 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.3 m -53.77 -44.95 70.46 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.986 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.31 -36.07 21.95 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.575 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.8 m -72.78 -33.14 66.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.062 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -66.39 -44.63 82.54 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.87 -76.57 1.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.78 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' GLY . 25.7 m-20 -83.98 103.45 13.24 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 0.0 110.543 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.14 79.81 3.66 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.251 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.7 p90 -72.11 161.33 79.46 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.461 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -50.53 -43.26 45.9 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 114.816 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.02 -6.14 43.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.285 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.46 123.12 85.86 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.106 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.637 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 18.6 Cg_endo -63.09 172.07 5.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.031 1.821 . . . . 0.0 112.298 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.5 140.12 80.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.14 2.56 . . . . 0.0 114.16 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.02 15.74 50.65 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.054 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.01 -43.72 16.03 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.113 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 7.8 p -88.34 148.59 24.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.891 0.377 . . . . 0.0 110.934 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.666 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . 142.68 -64.16 0.5 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.441 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER 50.63 11.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 28' ' ' VAL . 8.5 p -128.97 78.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.46 0.648 . . . . 0.0 111.064 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.33 57.66 1.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.228 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.2 tp -167.46 92.2 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.7 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 CA-C-O 120.388 -0.118 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 66.59 119.4 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.945 0.372 . . . . 0.0 110.517 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.707 ' C ' HD13 ' A' ' 4' ' ' ILE . 1.1 tm0? -137.54 111.64 8.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.111 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.707 HD13 ' C ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -137.1 -46.18 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.384 0.611 . . . . 0.0 109.418 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.16 161.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.233 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.61 -72.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.139 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.9 m -155.83 -86.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.499 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 10.4 m -73.07 112.16 14.43 Favored Pre-proline 0 N--CA 1.447 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.418 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.57 -178.13 3.53 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.72 1.613 . . . . 0.0 112.836 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.479 ' OG ' HD11 ' A' ' 30' ' ' LEU . 63.8 m -53.47 -44.71 69.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.695 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.56 -34.22 19.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.342 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 1.7 m -72.76 -34.83 67.27 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.819 ' HB3' ' HA ' ' A' ' 28' ' ' VAL . 50.8 m -66.01 -47.81 73.23 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.03 -73.92 1.19 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.232 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -84.05 103.28 13.15 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.786 0.803 . . . . 0.0 110.36 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.54 79.42 4.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.609 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.4 p90 -72.66 158.77 86.8 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.049 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.88 -42.04 66.52 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.627 2.218 . . . . 0.0 114.924 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.04 -3.75 31.23 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.323 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 32.1 m -66.95 122.67 83.53 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.451 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.499 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 81.4 Cg_exo -45.33 163.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.86 1.707 . . . . 0.0 113.033 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.59 140.07 46.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.88 2.387 . . . . 0.0 112.378 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.75 14.06 27.84 Favored Glycine 0 C--N 1.317 -0.52 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.55 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -41.51 17.94 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.826 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 31.2 p -88.92 146.89 24.64 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.901 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 -64.43 0.45 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.984 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -52.15 -27.45 14.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.206 0.526 . . . . 0.0 111.729 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.819 ' HA ' ' HB3' ' A' ' 13' ' ' SER . 7.1 p 35.48 89.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.524 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -145.49 155.39 43.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.972 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.479 HD11 ' OG ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -134.77 52.18 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.416 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.747 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.8 p -153.52 -23.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.649 0.262 . . . . 0.0 111.2 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.88 -25.1 1.11 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.119 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.723 HG13 ' H ' ' A' ' 5' ' ' THR . 8.5 tp -54.98 -178.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.648 0.379 . . . . 0.0 111.17 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.723 ' H ' HG13 ' A' ' 4' ' ' ILE . 9.9 p -71.81 -34.41 69.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.297 0.57 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.516 ' H ' HG23 ' A' ' 4' ' ' ILE . . . 130.32 -66.06 0.58 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.832 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 m -85.5 -68.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.369 . . . . 0.0 111.53 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 63.1 m -72.31 141.92 83.92 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.23 -179.19 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.083 1.855 . . . . 0.0 113.099 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.611 ' HA ' HD11 ' A' ' 4' ' ' ILE . 48.4 m -54.63 -52.74 61.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.242 -1.345 . . . . 0.0 112.661 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.84 -37.42 21.5 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.947 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.579 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -72.87 -31.54 64.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.849 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -66.91 -45.55 77.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.4 -75.84 1.23 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.959 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 11' ' ' GLY . 61.7 m-20 -83.92 103.78 13.47 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.739 0.78 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.15 78.76 3.68 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.046 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 3.4 p90 -72.31 159.86 84.29 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.192 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.44 -43.07 39.91 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.557 2.171 . . . . 0.0 114.867 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -73.01 -5.79 41.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.15 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 73.5 m -67.5 122.87 85.06 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.346 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.737 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 10.1 Cg_endo -60.25 168.86 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 121.677 1.584 . . . . 0.0 112.139 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.56 140.45 87.08 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.175 2.583 . . . . 0.0 114.017 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.71 17.35 53.94 Favored Glycine 0 C--N 1.319 -0.385 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.976 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.737 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -83.33 -41.77 17.85 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.879 179.328 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.579 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 4.6 p -88.16 140.73 29.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.071 0.463 . . . . 0.0 111.37 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.5 65.41 0.19 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.105 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.486 ' HG2' HG23 ' A' ' 28' ' ' VAL . 1.7 pt20 -68.69 -4.49 15.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.486 HG23 ' HG2' ' A' ' 27' ' ' GLN . 37.6 t -136.28 81.75 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.162 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -72.61 141.15 48.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 30' ' ' LEU . 6.2 mp -99.4 35.96 1.85 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.74 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.033 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.28 116.81 29.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 0.0 110.936 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -139.7 152.66 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.759 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -98.46 -33.31 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.809 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.83 153.87 17.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.19 -102.34 2.46 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.689 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 88.2 m -84.38 -49.4 8.74 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 9.8 m -73.51 108.93 5.43 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.797 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 7' ' ' THR . 57.1 Cg_endo -76.35 -176.75 3.25 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.807 1.671 . . . . 0.0 112.574 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m -52.98 -43.11 66.16 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.557 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.47 -34.45 19.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.191 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.507 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 2.4 m -72.93 -36.44 67.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.972 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.25 -44.48 83.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.53 -74.87 1.2 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.511 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -83.89 103.42 13.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.672 0.749 . . . . 0.0 110.73 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.41 79.11 3.92 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.111 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.2 p90 -73.02 159.7 84.64 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.27 -40.75 81.09 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 122.635 2.223 . . . . 0.0 115.094 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.15 -3.5 30.09 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.534 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.414 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 47.3 m -66.84 122.19 81.2 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.798 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 86.4 Cg_exo -48.46 141.38 19.61 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.972 1.782 . . . . 0.0 112.995 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -44.77 139.63 7.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.608 2.205 . . . . 0.0 113.512 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.61 14.36 35.48 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.48 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.798 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.36 -40.34 19.54 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.397 178.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 30.3 p -88.68 145.33 25.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.07 0.462 . . . . 0.0 111.217 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.74 63.5 0.28 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.967 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -0.15 7.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.887 0.375 . . . . 0.0 111.77 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 28' ' ' VAL . 11.3 p -99.58 67.84 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.652 0.739 . . . . 0.0 110.981 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -174.0 146.47 1.19 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.555 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.26 40.16 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.036 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.4 t30 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.852 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.4 p -160.34 159.45 31.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 110.836 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -119.27 78.65 1.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.709 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.57 HD12 HG23 ' A' ' 5' ' ' THR . 1.4 pt -62.06 -39.59 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.257 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.57 HG23 HD12 ' A' ' 4' ' ' ILE . 29.0 p -102.72 -59.19 1.75 Allowed 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.311 0.577 . . . . 0.0 111.11 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.3 76.55 0.23 Allowed Glycine 0 C--N 1.316 -0.532 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.471 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.3 m -84.85 -48.2 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.255 0.55 . . . . 0.0 111.107 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 10.6 m -72.47 113.13 18.25 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.359 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.01 -178.45 3.87 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.823 1.682 . . . . 0.0 113.164 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -53.77 -45.14 70.54 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.979 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.41 -34.72 14.01 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.074 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 2.3 m -72.66 -34.91 67.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.747 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.36 -45.28 80.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.87 -75.14 1.17 Allowed Glycine 0 C--N 1.316 -0.548 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.41 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 11' ' ' GLY . 13.1 m-20 -84.01 103.7 13.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.678 0.752 . . . . 0.0 110.506 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.25 78.59 3.77 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.803 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.0 p90 -72.8 159.15 86.03 Favored Pre-proline 0 N--CA 1.446 -0.65 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.097 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.46 -42.54 60.63 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.654 2.236 . . . . 0.0 115.092 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.73 -3.46 28.55 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.418 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.5 m -67.09 122.69 83.81 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.251 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 94.1 Cg_exo -46.73 163.94 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.864 1.709 . . . . 0.0 112.893 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.8 139.92 49.32 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.8 2.334 . . . . 0.0 112.533 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.59 14.2 27.39 Favored Glycine 0 C--N 1.318 -0.442 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.523 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -40.81 18.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.694 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 29.8 p -88.93 147.04 24.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.979 0.419 . . . . 0.0 110.981 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.56 61.23 5.5 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.395 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.72 94.08 3.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.644 0.735 . . . . 0.0 110.575 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.3 t 46.8 90.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.496 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -136.26 105.0 5.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.632 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 mt -141.88 -77.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.074 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 t30 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.915 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.58 37.64 4.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.905 0.383 . . . . 0.0 110.756 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.23 144.6 24.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 7' ' ' THR . 8.2 tp -53.55 154.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.685 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.45 -17.77 6.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.401 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.23 -77.9 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.105 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.487 ' O ' HD11 ' A' ' 4' ' ' ILE . 81.4 m -155.55 -87.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 31.9 m -72.31 114.9 33.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.7 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.0 -179.69 5.24 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.844 1.696 . . . . 0.0 113.113 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -53.79 -45.4 70.7 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.182 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -48.24 -33.93 11.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 2.3 m -72.98 -35.17 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 121.311 -0.155 . . . . 0.0 110.82 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.566 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.1 m -66.19 -46.53 76.98 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.33 -74.37 1.18 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.366 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 11' ' ' GLY . 41.0 m-20 -83.71 103.44 13.01 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.755 0.788 . . . . 0.0 110.378 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.47 78.24 3.98 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.581 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.3 p90 -72.86 159.15 86.01 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.374 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.85 -42.61 62.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.727 2.284 . . . . 0.0 115.025 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -73.86 -2.67 24.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 33.2 m -66.83 122.38 82.07 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.984 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.778 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 83.6 Cg_exo -50.28 139.92 35.02 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.909 1.739 . . . . 0.0 113.131 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -43.94 140.09 5.25 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.01 2.473 . . . . 0.0 114.276 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.45 14.36 41.43 Favored Glycine 0 N--CA 1.465 0.583 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.667 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.778 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -84.11 -39.98 18.83 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.862 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 27.9 p -89.53 149.75 22.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.067 0.461 . . . . 0.0 111.881 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.67 69.05 1.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.267 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.754 ' HG2' HG23 ' A' ' 28' ' ' VAL . 18.7 pm0 -118.44 -24.36 6.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.35 . . . . 0.0 111.412 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.754 HG23 ' HG2' ' A' ' 27' ' ' GLN . 23.1 t -149.99 89.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.009 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 58.53 91.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 111.019 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 13' ' ' SER . 3.1 tp -83.46 -59.38 2.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.926 -179.909 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo . . . . . 0 N--CA 1.464 -0.257 0 CA-C-O 121.546 0.561 . . . . 0.0 112.996 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.0 m -53.5 -45.43 69.66 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.777 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.66 -34.58 21.22 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.38 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.421 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.61 -35.09 67.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.13 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -66.2 -43.91 85.42 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.24 -76.27 1.18 Allowed Glycine 0 C--N 1.317 -0.511 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.426 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -83.91 103.52 13.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.587 0.708 . . . . 0.0 110.16 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 t -77.29 78.84 3.82 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.508 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.2 p90 -72.42 160.58 82.42 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.64 -39.88 74.7 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.664 2.242 . . . . 0.0 115.398 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.45 -7.82 51.83 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.218 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.405 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 90.3 m -67.53 123.48 86.83 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -65.69 147.17 85.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.072 1.848 . . . . 0.0 112.226 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -37.33 138.97 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.444 2.763 . . . . 0.0 115.068 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 0.273 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.913 178.451 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo . . . . . 0 N--CA 1.465 -0.156 0 CA-C-O 121.745 0.644 . . . . 0.0 113.347 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.4 m -54.22 -47.02 72.63 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.452 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.42 -35.68 21.85 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.464 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.421 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.9 m -72.92 -34.08 66.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.083 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -66.51 -44.64 81.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.71 -74.92 1.23 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.023 -1.085 . . . . 0.0 112.702 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' GLY . 53.9 m-20 -83.59 103.44 12.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.716 0.769 . . . . 0.0 110.068 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.7 79.04 4.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.013 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 p90 -72.24 159.27 85.86 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.174 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.52 -44.06 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.469 2.113 . . . . 0.0 114.593 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.79 -3.8 30.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.367 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 22.4 m -67.08 122.48 82.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.327 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -46.64 162.61 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.938 1.759 . . . . 0.0 112.664 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.45 140.39 52.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.854 2.369 . . . . 0.0 112.877 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.316 -0.547 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.478 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 N--CA 1.463 -0.314 0 CA-C-O 121.743 0.643 . . . . 0.0 113.499 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m -54.11 -46.72 72.22 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.549 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.3 -36.86 23.54 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.73 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.416 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.81 -33.19 66.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.107 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.4 m -66.26 -46.37 77.3 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.08 -75.29 1.18 Allowed Glycine 0 C--N 1.315 -0.608 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.455 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 11' ' ' GLY . 1.3 m-20 -84.0 103.48 13.28 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.585 0.707 . . . . 0.0 110.518 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 t -77.36 78.65 3.88 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.224 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.8 p90 -72.24 159.94 84.06 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.625 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.51 -43.62 38.23 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.844 2.362 . . . . 0.0 114.934 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -72.92 -5.38 38.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.239 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -67.5 123.56 87.01 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -63.2 168.69 10.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.95 1.766 . . . . 0.0 112.275 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.46 140.39 81.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.062 2.508 . . . . 0.0 113.75 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.417 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.074 179.572 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo . . . . . 0 N--CA 1.46 -0.497 0 CA-C-O 122.066 0.777 . . . . 0.0 112.817 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.2 m -54.83 -48.66 72.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.517 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.58 -37.25 26.23 Favored Glycine 0 CA--C 1.503 -0.714 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.589 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.44 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.4 m -72.5 -32.59 66.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.654 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -67.0 -44.99 78.95 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.33 -74.8 1.26 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.088 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 59.6 m-20 -83.7 103.36 12.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.81 0.814 . . . . 0.0 110.035 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.29 78.28 3.82 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.388 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.3 p90 -72.34 159.22 85.96 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.869 -0.733 . . . . 0.0 109.432 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -49.34 -41.99 41.7 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.729 2.286 . . . . 0.0 115.154 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.13 -6.9 48.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.135 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -67.45 123.58 87.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -63.43 166.28 15.61 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.784 1.656 . . . . 0.0 112.339 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.89 140.18 85.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.889 2.393 . . . . 0.0 114.676 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.245 0 CA-C-N 114.164 -1.38 . . . . 0.0 113.843 178.15 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo . . . . . 0 N--CA 1.463 -0.294 0 CA-C-O 121.477 0.532 . . . . 0.0 112.65 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.3 m -53.77 -44.95 70.46 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.986 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.31 -36.07 21.95 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.575 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.423 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.8 m -72.78 -33.14 66.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.062 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -66.39 -44.63 82.54 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.87 -76.57 1.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.78 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' GLY . 25.7 m-20 -83.98 103.45 13.24 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 0.0 110.543 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.14 79.81 3.66 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.251 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.7 p90 -72.11 161.33 79.46 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.461 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -50.53 -43.26 45.9 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 114.816 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.02 -6.14 43.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.285 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.46 123.12 85.86 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.106 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -63.09 172.07 5.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.031 1.821 . . . . 0.0 112.298 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.5 140.12 80.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.14 2.56 . . . . 0.0 114.16 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.457 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.054 179.026 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo . . . . . 0 N--CA 1.461 -0.384 0 CA-C-O 121.46 0.525 . . . . 0.0 112.836 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 63.8 m -53.47 -44.71 69.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.695 177.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.56 -34.22 19.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.342 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.45 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.76 -34.83 67.27 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 50.8 m -66.01 -47.81 73.23 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.03 -73.92 1.19 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.232 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -84.05 103.28 13.15 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.786 0.803 . . . . 0.0 110.36 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.54 79.42 4.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.609 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.4 p90 -72.66 158.77 86.8 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.049 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.88 -42.04 66.52 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.627 2.218 . . . . 0.0 114.924 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.04 -3.75 31.23 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.323 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 32.1 m -66.95 122.67 83.53 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.451 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -45.33 163.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.86 1.707 . . . . 0.0 113.033 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.59 140.07 46.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.88 2.387 . . . . 0.0 112.378 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.52 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.55 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo . . . . . 0 N--CA 1.464 -0.207 0 CA-C-O 121.854 0.689 . . . . 0.0 113.099 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 48.4 m -54.63 -52.74 61.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.242 -1.345 . . . . 0.0 112.661 178.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.84 -37.42 21.5 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.947 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.417 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 1.7 m -72.87 -31.54 64.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.849 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -66.91 -45.55 77.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.4 -75.84 1.23 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.959 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 11' ' ' GLY . 61.7 m-20 -83.92 103.78 13.47 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.739 0.78 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.15 78.76 3.68 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.046 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 3.4 p90 -72.31 159.86 84.29 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.192 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.44 -43.07 39.91 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.557 2.171 . . . . 0.0 114.867 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -73.01 -5.79 41.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.15 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 73.5 m -67.5 122.87 85.06 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.346 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -60.25 168.86 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 121.677 1.584 . . . . 0.0 112.139 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.56 140.45 87.08 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.175 2.583 . . . . 0.0 114.017 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.319 -0.385 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.976 179.302 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo . . . . . 0 N--CA 1.462 -0.375 0 CA-C-O 121.382 0.493 . . . . 0.0 112.574 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m -52.98 -43.11 66.16 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.557 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.47 -34.45 19.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.191 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.431 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 2.4 m -72.93 -36.44 67.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.972 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.25 -44.48 83.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.53 -74.87 1.2 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.511 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -83.89 103.42 13.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.672 0.749 . . . . 0.0 110.73 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.41 79.11 3.92 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.111 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.2 p90 -73.02 159.7 84.64 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.27 -40.75 81.09 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 122.635 2.223 . . . . 0.0 115.094 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.15 -3.5 30.09 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.534 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.414 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 47.3 m -66.84 122.19 81.2 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -48.46 141.38 19.61 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.972 1.782 . . . . 0.0 112.995 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -44.77 139.63 7.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.608 2.205 . . . . 0.0 113.512 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.53 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.48 179.186 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo . . . . . 0 N--CA 1.463 -0.311 0 CA-C-O 121.573 0.572 . . . . 0.0 113.164 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -53.77 -45.14 70.54 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.979 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.41 -34.72 14.01 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.074 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.439 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 2.3 m -72.66 -34.91 67.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.747 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.36 -45.28 80.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.87 -75.14 1.17 Allowed Glycine 0 C--N 1.316 -0.548 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.41 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 11' ' ' GLY . 13.1 m-20 -84.01 103.7 13.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.678 0.752 . . . . 0.0 110.506 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.25 78.59 3.77 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.803 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.0 p90 -72.8 159.15 86.03 Favored Pre-proline 0 N--CA 1.446 -0.65 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.097 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.46 -42.54 60.63 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.654 2.236 . . . . 0.0 115.092 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.73 -3.46 28.55 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.418 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.5 m -67.09 122.69 83.81 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.251 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -46.73 163.94 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.864 1.709 . . . . 0.0 112.893 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.8 139.92 49.32 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.8 2.334 . . . . 0.0 112.533 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.442 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.523 -179.615 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo . . . . . 0 CA--C 1.528 0.218 0 CA-C-O 121.506 0.544 . . . . 0.0 113.113 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -53.79 -45.4 70.7 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.182 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -48.24 -33.93 11.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.456 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 2.3 m -72.98 -35.17 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 121.311 -0.155 . . . . 0.0 110.82 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 m -66.19 -46.53 76.98 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.33 -74.37 1.18 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.366 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 11' ' ' GLY . 41.0 m-20 -83.71 103.44 13.01 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.755 0.788 . . . . 0.0 110.378 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.47 78.24 3.98 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.581 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.3 p90 -72.86 159.15 86.01 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.374 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.85 -42.61 62.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.727 2.284 . . . . 0.0 115.025 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -73.86 -2.67 24.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 33.2 m -66.83 122.38 82.07 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.984 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -50.28 139.92 35.02 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.909 1.739 . . . . 0.0 113.131 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -43.94 140.09 5.25 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.01 2.473 . . . . 0.0 114.276 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.583 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.667 178.791 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 112.607 -0.197 . . . . 0.0 112.607 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.3 m -132.99 -45.88 0.85 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.755 0.312 . . . . 0.0 110.935 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.8 tp60 -96.21 -25.14 15.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.903 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.568 HG23 ' N ' ' A' ' 5' ' ' THR . 0.2 OUTLIER 41.76 -166.23 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.568 ' N ' HG23 ' A' ' 4' ' ' ILE . 68.9 p -120.58 138.87 53.65 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.825 0.345 . . . . 0.0 111.047 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.6 -91.22 0.35 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.86 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.0 m -84.95 -50.29 7.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.219 0.533 . . . . 0.0 111.386 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.575 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 35.3 m -72.12 116.08 45.11 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.309 -0.859 . . . . 0.0 112.11 -177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -72.28 -176.72 2.31 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.006 1.804 . . . . 0.0 112.996 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 71.0 m -53.5 -45.43 69.66 Favored 'General case' 0 CA--C 1.505 -0.781 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.777 177.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.66 -34.58 21.22 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 114.829 -1.078 . . . . 0.0 111.38 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.595 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -72.61 -35.09 67.76 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.13 178.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 37.1 p -66.2 -43.91 85.42 Favored 'General case' 0 CA--C 1.508 -0.663 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.24 -76.27 1.18 Allowed Glycine 0 C--N 1.317 -0.511 0 C-N-CA 119.879 -1.153 . . . . 0.0 112.426 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 11' ' ' GLY . 0.7 OUTLIER -83.91 103.52 13.24 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-O 121.587 0.708 . . . . 0.0 110.16 179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.9 t -77.29 78.84 3.82 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.508 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.2 p90 -72.42 160.58 82.42 Favored Pre-proline 0 N--CA 1.448 -0.575 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -52.64 -39.88 74.7 Favored 'Trans proline' 0 CA--C 1.518 -0.321 0 C-N-CA 122.664 2.242 . . . . 0.0 115.398 -176.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -72.45 -7.82 51.83 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 119.219 -0.992 . . . . 0.0 112.218 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.405 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 90.3 m -67.53 123.48 86.83 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.708 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 31.4 Cg_endo -65.69 147.17 85.7 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.072 1.848 . . . . 0.0 112.226 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -37.33 138.97 0.26 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.444 2.763 . . . . 0.0 115.068 -178.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.55 15.84 48.19 Favored Glycine 0 CA--C 1.518 0.273 0 CA-C-N 114.324 -1.307 . . . . 0.0 113.913 178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.708 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.14 -39.63 20.81 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.194 178.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.595 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 6.4 p -88.15 141.73 28.33 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 120.865 0.364 . . . . 0.0 110.777 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 48.05 58.48 7.01 Favored Glycine 0 N--CA 1.454 -0.151 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.822 -179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.7 4.19 7.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.807 0.337 . . . . 0.0 111.56 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 28' ' ' VAL . 9.2 p -132.11 80.63 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.6 0.714 . . . . 0.0 111.169 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.406 ' C ' ' H ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -156.63 115.56 3.4 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.416 179.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.5 mp -76.37 26.73 0.13 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 120.57 0.224 . . . . 0.0 111.496 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 29' ' ' ASN . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.757 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.22 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.78 127.1 30.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.815 0.341 . . . . 0.0 110.874 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -161.63 33.96 0.13 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.803 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 6' ' ' GLY . 37.8 mm -103.29 160.09 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.343 -179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.48 ' N ' HG22 ' A' ' 4' ' ' ILE . 14.1 p -75.31 -34.72 61.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.511 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.608 ' H ' HG22 ' A' ' 4' ' ' ILE . . . -173.06 77.13 0.09 OUTLIER Glycine 0 C--N 1.319 -0.392 0 CA-C-N 115.626 -0.716 . . . . 0.0 113.09 -179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.511 ' OG1' HG21 ' A' ' 4' ' ' ILE . 63.9 m -85.3 -55.25 4.12 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.25 0.547 . . . . 0.0 111.208 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.565 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 56.3 m -71.56 126.47 91.64 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.292 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -68.41 -178.45 1.85 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.077 1.851 . . . . 0.0 113.347 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 44.4 m -54.22 -47.02 72.63 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 114.293 -1.321 . . . . 0.0 111.452 177.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.478 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.42 -35.68 21.85 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.464 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.57 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.9 m -72.92 -34.08 66.38 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.083 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.4 t -66.51 -44.64 81.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.71 -74.92 1.23 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.023 -1.085 . . . . 0.0 112.702 176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' GLY . 53.9 m-20 -83.59 103.44 12.91 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.716 0.769 . . . . 0.0 110.068 179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.6 t -77.7 79.04 4.2 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.013 178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.421 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 5.7 p90 -72.24 159.27 85.86 Favored Pre-proline 0 N--CA 1.446 -0.647 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.174 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -51.52 -44.06 46.27 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 122.469 2.113 . . . . 0.0 114.593 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -73.79 -3.8 30.77 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 119.62 -0.832 . . . . 0.0 112.367 -177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.404 ' SG ' ' CZ ' ' A' ' 17' ' ' TYR . 22.4 m -67.08 122.48 82.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 119.31 -0.956 . . . . 0.0 109.327 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.565 ' HD2' ' SG ' ' A' ' 8' ' ' CYS . 87.4 Cg_exo -46.64 162.61 0.14 Allowed 'Trans proline' 0 C--N 1.353 0.807 0 C-N-CA 121.938 1.759 . . . . 0.0 112.664 179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -67.45 140.39 52.34 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.854 2.369 . . . . 0.0 112.877 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.85 16.11 50.81 Favored Glycine 0 C--N 1.316 -0.547 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.478 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.58 -38.72 21.28 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.43 178.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 9.6 p -88.79 143.66 26.76 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 121.018 0.437 . . . . 0.0 111.35 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 162.92 65.5 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.529 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.619 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -73.17 0.49 11.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.184 0.438 . . . . 0.0 112.184 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.57 ' O ' HG13 ' A' ' 28' ' ' VAL . 8.2 p -123.19 76.67 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.608 0.718 . . . . 0.0 111.18 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -166.5 151.65 8.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.533 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 30' ' ' LEU . 1.7 mp -92.33 34.73 1.03 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.559 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 t30 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.783 -179.898 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.9 -44.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.946 0.403 . . . . 0.0 110.905 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.499 ' C ' HD13 ' A' ' 4' ' ' ILE . 32.3 tt0 -165.86 -22.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.407 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.605 ' N ' HD13 ' A' ' 4' ' ' ILE . 2.4 mm -93.03 37.19 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 CA-C-O 121.964 0.888 . . . . 0.0 110.483 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.1 t -136.43 -176.84 4.47 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.692 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -151.49 -91.66 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.104 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 71.2 m -154.97 -61.72 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.066 0.46 . . . . 0.0 111.329 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.487 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 91.0 m -70.96 122.93 88.36 Favored Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.674 -0.694 . . . . 0.0 112.395 -175.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.3 -178.83 2.75 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.992 1.795 . . . . 0.0 113.499 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 53.3 m -54.11 -46.72 72.22 Favored 'General case' 0 CA--C 1.506 -0.719 0 CA-C-N 114.241 -1.345 . . . . 0.0 111.549 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.3 -36.86 23.54 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.73 -178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.552 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -72.81 -33.19 66.06 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.107 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.567 ' HB3' ' HG2' ' A' ' 27' ' ' GLN . 7.4 m -66.26 -46.37 77.3 Favored 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.08 -75.29 1.18 Allowed Glycine 0 C--N 1.315 -0.608 0 C-N-CA 120.02 -1.086 . . . . 0.0 112.455 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 11' ' ' GLY . 1.3 m-20 -84.0 103.48 13.28 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.585 0.707 . . . . 0.0 110.518 179.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.8 t -77.36 78.65 3.88 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.023 -0.99 . . . . 0.0 111.224 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.416 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.8 p90 -72.24 159.94 84.06 Favored Pre-proline 0 N--CA 1.449 -0.506 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.625 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -49.51 -43.62 38.23 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.844 2.362 . . . . 0.0 114.934 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -72.92 -5.38 38.1 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.17 -1.012 . . . . 0.0 112.239 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 90.0 m -67.5 123.56 87.01 Favored Pre-proline 0 CA--C 1.536 0.429 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.72 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 19.2 Cg_endo -63.2 168.69 10.5 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.95 1.766 . . . . 0.0 112.275 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -62.46 140.39 81.74 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.062 2.508 . . . . 0.0 113.75 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 63.25 14.35 53.31 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 114.307 -1.315 . . . . 0.0 113.074 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.72 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.32 -44.16 15.2 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.351 -0.54 . . . . 0.0 110.48 178.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.552 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 18.6 p -88.4 146.95 24.96 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.023 0.44 . . . . 0.0 111.42 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.17 71.6 1.06 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.399 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.567 ' HG2' ' HB3' ' A' ' 13' ' ' SER . 1.0 OUTLIER -106.94 0.14 23.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.875 0.369 . . . . 0.0 111.385 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.583 ' O ' HG13 ' A' ' 28' ' ' VAL . 14.2 p -91.28 65.78 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.795 0.807 . . . . 0.0 111.032 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -166.77 95.21 0.51 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.654 179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.3 mt -69.17 -58.9 3.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.964 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.942 -179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.566 -0.213 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 97.5 p -74.12 96.81 2.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.806 0.336 . . . . 0.0 110.816 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -157.35 152.1 25.5 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.802 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 5' ' ' THR . 0.2 OUTLIER 44.51 -173.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 112.235 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.487 ' N ' HG23 ' A' ' 4' ' ' ILE . 12.6 t -154.99 -164.06 1.71 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.526 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -142.67 -89.94 0.13 Allowed Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.186 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.457 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 52.4 m -155.38 -71.4 0.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.15 0.5 . . . . 0.0 110.347 179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.476 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 81.4 m -71.91 108.64 4.33 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.508 -177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 7' ' ' THR . 14.6 Cg_exo -60.11 -173.64 0.08 OUTLIER 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 121.981 1.788 . . . . 0.0 112.817 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.2 m -54.83 -48.66 72.56 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 113.589 -1.641 . . . . 0.0 111.517 176.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.58 -37.25 26.23 Favored Glycine 0 CA--C 1.503 -0.714 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.589 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.573 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.4 m -72.5 -32.59 66.3 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 120.172 -0.611 . . . . 0.0 109.654 178.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 m -67.0 -44.99 78.95 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 108.353 -0.981 . . . . 0.0 108.353 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -86.33 -74.8 1.26 Allowed Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 114.936 -1.029 . . . . 0.0 113.088 177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' N ' ' O ' ' A' ' 11' ' ' GLY . 59.6 m-20 -83.7 103.36 12.94 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.81 0.814 . . . . 0.0 110.035 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.29 78.28 3.82 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 114.477 -1.238 . . . . 0.0 111.388 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.3 p90 -72.34 159.22 85.96 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.869 -0.733 . . . . 0.0 109.432 179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -49.34 -41.99 41.7 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.729 2.286 . . . . 0.0 115.154 -177.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -73.13 -6.9 48.76 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.276 -0.97 . . . . 0.0 112.135 -177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.4 m -67.45 123.58 87.01 Favored Pre-proline 0 CA--C 1.533 0.293 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.537 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 19.9 Cg_endo -63.43 166.28 15.61 Favored 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 121.784 1.656 . . . . 0.0 112.339 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -55.89 140.18 85.17 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.889 2.393 . . . . 0.0 114.676 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.93 16.55 52.63 Favored Glycine 0 C--N 1.322 -0.245 0 CA-C-N 114.164 -1.38 . . . . 0.0 113.843 178.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.537 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.09 -40.39 19.9 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.442 178.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.573 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 4.2 p -88.2 141.77 28.29 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.889 0.376 . . . . 0.0 110.877 -179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.47 ' O ' ' CG ' ' A' ' 27' ' ' GLN . . . 160.79 -62.98 0.29 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.547 -179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.47 ' CG ' ' O ' ' A' ' 26' ' ' GLY . 5.4 pt20 54.49 10.23 0.32 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.593 0.59 . . . . 0.0 112.593 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.5 t 61.51 105.03 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.536 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.0 t-20 71.75 119.17 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.057 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.455 ' HG ' HE21 ' A' ' 27' ' ' GLN . 0.0 OUTLIER -122.97 -76.55 0.59 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.937 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.185 -0.912 . . . . 0.0 110.904 -179.834 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 25.3 p -72.08 116.73 12.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.859 0.361 . . . . 0.0 110.824 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -139.44 -18.11 0.99 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.34 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -104.73 -32.94 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 120.73 0.3 . . . . 0.0 111.093 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -159.32 169.84 23.14 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.915 0.388 . . . . 0.0 111.187 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.27 91.52 2.22 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.918 -0.658 . . . . 0.0 111.727 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 76.5 m -155.36 -79.21 0.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 110.573 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.558 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 74.1 m -72.21 118.16 64.8 Favored Pre-proline 0 N--CA 1.447 -0.607 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -176.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -71.41 -176.77 2.08 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.069 1.846 . . . . 0.0 112.65 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 62.3 m -53.77 -44.95 70.46 Favored 'General case' 0 CA--C 1.505 -0.761 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.986 177.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -49.31 -36.07 21.95 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 114.919 -1.037 . . . . 0.0 111.575 -179.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.577 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.8 m -72.78 -33.14 66.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 120.629 -0.428 . . . . 0.0 110.062 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 75.2 m -66.39 -44.63 82.54 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.87 -76.57 1.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.78 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.441 ' N ' ' O ' ' A' ' 11' ' ' GLY . 25.7 m-20 -83.98 103.45 13.24 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.595 0.712 . . . . 0.0 110.543 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.14 79.81 3.66 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.251 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.423 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 4.7 p90 -72.11 161.33 79.46 Favored Pre-proline 0 N--CA 1.448 -0.554 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.461 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_exo -50.53 -43.26 45.9 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.501 2.134 . . . . 0.0 114.816 -177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -73.02 -6.14 43.52 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 119.37 -0.932 . . . . 0.0 112.285 -177.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 82.4 m -67.46 123.12 85.86 Favored Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 118.884 -1.126 . . . . 0.0 108.106 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.637 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 18.6 Cg_endo -63.09 172.07 5.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.031 1.821 . . . . 0.0 112.298 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -62.5 140.12 80.06 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 123.14 2.56 . . . . 0.0 114.16 -178.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 62.02 15.74 50.65 Favored Glycine 0 C--N 1.318 -0.457 0 CA-C-N 114.21 -1.359 . . . . 0.0 113.054 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.637 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.5 OUTLIER -83.01 -43.72 16.03 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.035 -0.666 . . . . 0.0 110.113 179.03 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 7.8 p -88.34 148.59 24.2 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 120.891 0.377 . . . . 0.0 110.934 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.666 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . 142.68 -64.16 0.5 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.441 -179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 26' ' ' GLY . 0.9 OUTLIER 50.63 11.01 0.07 Allowed 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 28' ' ' VAL . 8.5 p -128.97 78.73 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.46 0.648 . . . . 0.0 111.064 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -134.33 57.66 1.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.228 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.2 tp -167.46 92.2 0.39 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.851 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.186 -0.911 . . . . 0.0 110.7 -179.899 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 CA-C-O 120.388 -0.118 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 66.59 119.4 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.945 0.372 . . . . 0.0 110.517 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.707 ' C ' HD13 ' A' ' 4' ' ' ILE . 1.1 tm0? -137.54 111.64 8.43 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.111 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.707 HD13 ' C ' ' A' ' 3' ' ' GLN . 0.0 OUTLIER -137.1 -46.18 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-O 121.384 0.611 . . . . 0.0 109.418 179.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.16 161.8 1.63 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.233 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.61 -72.07 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.139 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.9 m -155.83 -86.23 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.499 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 10.4 m -73.07 112.16 14.43 Favored Pre-proline 0 N--CA 1.447 -0.593 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.418 -178.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.57 -178.13 3.53 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 121.72 1.613 . . . . 0.0 112.836 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.479 ' OG ' HD11 ' A' ' 30' ' ' LEU . 63.8 m -53.47 -44.71 69.15 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.695 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.5 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.56 -34.22 19.68 Favored Glycine 0 N--CA 1.445 -0.717 0 CA-C-N 114.628 -1.169 . . . . 0.0 111.342 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.519 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 1.7 m -72.76 -34.83 67.27 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.819 ' HB3' ' HA ' ' A' ' 28' ' ' VAL . 50.8 m -66.01 -47.81 73.23 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.03 -73.92 1.19 Allowed Glycine 0 N--CA 1.445 -0.765 0 CA-C-N 114.447 -1.251 . . . . 0.0 112.232 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.5 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -84.05 103.28 13.15 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.786 0.803 . . . . 0.0 110.36 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.54 79.42 4.04 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.84 -1.073 . . . . 0.0 111.609 178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.4 p90 -72.66 158.77 86.8 Favored Pre-proline 0 N--CA 1.445 -0.687 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.049 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.88 -42.04 66.52 Favored 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.627 2.218 . . . . 0.0 114.924 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -74.04 -3.75 31.23 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 119.721 -0.792 . . . . 0.0 112.323 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.421 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 32.1 m -66.95 122.67 83.53 Favored Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 119.504 -0.878 . . . . 0.0 109.451 178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.499 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 81.4 Cg_exo -45.33 163.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.354 0.84 0 C-N-CA 121.86 1.707 . . . . 0.0 113.033 179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -68.59 140.07 46.33 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.88 2.387 . . . . 0.0 112.378 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.75 14.06 27.84 Favored Glycine 0 C--N 1.317 -0.52 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.55 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -41.51 17.94 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.826 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 31.2 p -88.92 146.89 24.64 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 120.954 0.407 . . . . 0.0 110.901 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 120.02 -64.43 0.45 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.984 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -52.15 -27.45 14.41 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.206 0.526 . . . . 0.0 111.729 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.819 ' HA ' ' HB3' ' A' ' 13' ' ' SER . 7.1 p 35.48 89.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.524 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -145.49 155.39 43.07 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.972 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.479 HD11 ' OG ' ' A' ' 10' ' ' SER . 0.2 OUTLIER -134.77 52.18 2.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.416 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.747 -179.785 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 89.8 p -153.52 -23.65 0.14 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.649 0.262 . . . . 0.0 111.2 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.88 -25.1 1.11 Allowed 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.119 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.723 HG13 ' H ' ' A' ' 5' ' ' THR . 8.5 tp -54.98 -178.1 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 122.648 0.379 . . . . 0.0 111.17 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.723 ' H ' HG13 ' A' ' 4' ' ' ILE . 9.9 p -71.81 -34.41 69.32 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.297 0.57 . . . . 0.0 111.095 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.516 ' H ' HG23 ' A' ' 4' ' ' ILE . . . 130.32 -66.06 0.58 Allowed Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.832 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.4 m -85.5 -68.81 0.7 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.876 0.369 . . . . 0.0 111.53 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.538 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 63.1 m -72.31 141.92 83.92 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -61.23 -179.19 0.3 Allowed 'Trans proline' 0 C--N 1.359 1.089 0 C-N-CA 122.083 1.855 . . . . 0.0 113.099 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.611 ' HA ' HD11 ' A' ' 4' ' ' ILE . 48.4 m -54.63 -52.74 61.31 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-N 114.242 -1.345 . . . . 0.0 112.661 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.447 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.84 -37.42 21.5 Favored Glycine 0 CA--C 1.503 -0.679 0 CA-C-N 115.461 -0.791 . . . . 0.0 111.947 -178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.579 ' O ' ' HB3' ' A' ' 25' ' ' CYS . 1.7 m -72.87 -31.54 64.79 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 120.545 -0.462 . . . . 0.0 109.849 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.6 m -66.91 -45.55 77.61 Favored 'General case' 0 CA--C 1.51 -0.573 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -85.4 -75.84 1.23 Allowed Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 114.909 -1.041 . . . . 0.0 112.959 177.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 11' ' ' GLY . 61.7 m-20 -83.92 103.78 13.47 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 121.739 0.78 . . . . 0.0 110.325 179.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.4 t -77.15 78.76 3.68 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 114.66 -1.155 . . . . 0.0 111.046 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 3.4 p90 -72.31 159.86 84.29 Favored Pre-proline 0 N--CA 1.45 -0.469 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.192 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -49.44 -43.07 39.91 Favored 'Trans proline' 0 N--CA 1.461 -0.429 0 C-N-CA 122.557 2.171 . . . . 0.0 114.867 -177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -73.01 -5.79 41.2 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 119.339 -0.944 . . . . 0.0 112.15 -177.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.403 ' SG ' ' CE1' ' A' ' 17' ' ' TYR . 73.5 m -67.5 122.87 85.06 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 119.057 -1.057 . . . . 0.0 108.346 177.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.737 ' HG2' ' SG ' ' A' ' 24' ' ' CYS . 10.1 Cg_endo -60.25 168.86 5.68 Favored 'Trans proline' 0 CA--C 1.532 0.375 0 C-N-CA 121.677 1.584 . . . . 0.0 112.139 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -61.56 140.45 87.08 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.175 2.583 . . . . 0.0 114.017 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.71 17.35 53.94 Favored Glycine 0 C--N 1.319 -0.385 0 CA-C-N 114.278 -1.328 . . . . 0.0 112.976 179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.737 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -83.33 -41.77 17.85 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.466 -0.494 . . . . 0.0 110.879 179.328 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.579 ' HB3' ' O ' ' A' ' 12' ' ' CYS . 4.6 p -88.16 140.73 29.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.071 0.463 . . . . 0.0 111.37 -178.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -167.5 65.41 0.19 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.105 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.486 ' HG2' HG23 ' A' ' 28' ' ' VAL . 1.7 pt20 -68.69 -4.49 15.9 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.486 HG23 ' HG2' ' A' ' 27' ' ' GLN . 37.6 t -136.28 81.75 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.162 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -72.61 141.15 48.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.006 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 30' ' ' LEU . 6.2 mp -99.4 35.96 1.85 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.74 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.259 -0.877 . . . . 0.0 111.033 -179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 112.548 -0.221 . . . . 0.0 112.548 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.28 116.81 29.25 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.838 0.351 . . . . 0.0 110.936 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -139.7 152.66 46.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.759 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -98.46 -33.31 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.809 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -94.83 153.87 17.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.949 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.19 -102.34 2.46 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.689 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.465 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 88.2 m -84.38 -49.4 8.74 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.533 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 9.8 m -73.51 108.93 5.43 Favored Pre-proline 0 C--N 1.316 -0.883 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.797 -178.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 7' ' ' THR . 57.1 Cg_endo -76.35 -176.75 3.25 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 121.807 1.671 . . . . 0.0 112.574 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.7 m -52.98 -43.11 66.16 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.557 177.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.477 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -49.47 -34.45 19.51 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 114.571 -1.195 . . . . 0.0 111.191 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.507 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 2.4 m -72.93 -36.44 67.22 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 121.088 -0.245 . . . . 0.0 110.972 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.25 -44.48 83.6 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.53 -74.87 1.2 Allowed Glycine 0 C--N 1.314 -0.643 0 C-N-CA 119.856 -1.164 . . . . 0.0 112.511 176.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.477 ' O ' ' O ' ' A' ' 11' ' ' GLY . 49.4 m-20 -83.89 103.42 13.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.672 0.749 . . . . 0.0 110.73 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 t -77.41 79.11 3.92 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.111 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.431 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 6.2 p90 -73.02 159.7 84.64 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.27 -40.75 81.09 Favored 'Trans proline' 0 CA--C 1.519 -0.256 0 C-N-CA 122.635 2.223 . . . . 0.0 115.094 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -74.15 -3.5 30.09 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 119.795 -0.762 . . . . 0.0 112.534 -177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.414 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 47.3 m -66.84 122.19 81.2 Favored Pre-proline 0 CA--C 1.538 0.516 0 C-N-CA 118.971 -1.092 . . . . 0.0 109.428 179.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.798 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 86.4 Cg_exo -48.46 141.38 19.61 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 121.972 1.782 . . . . 0.0 112.995 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -44.77 139.63 7.41 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.608 2.205 . . . . 0.0 113.512 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 60.61 14.36 35.48 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 114.689 -1.141 . . . . 0.0 113.48 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.798 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.1 OUTLIER -83.36 -40.34 19.54 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.397 178.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.507 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 30.3 p -88.68 145.33 25.71 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 121.07 0.462 . . . . 0.0 111.217 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -160.74 63.5 0.28 Allowed Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.967 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.06 -0.15 7.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.887 0.375 . . . . 0.0 111.77 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.571 ' O ' HG13 ' A' ' 28' ' ' VAL . 11.3 p -99.58 67.84 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.652 0.739 . . . . 0.0 110.981 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.42 ' ND2' ' HB2' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -174.0 146.47 1.19 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.555 179.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.26 40.16 1.33 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.036 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.42 ' HB2' ' ND2' ' A' ' 29' ' ' ASN . 8.4 t30 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.852 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.482 -0.247 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.4 p -160.34 159.45 31.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.683 0.278 . . . . 0.0 110.836 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.6 tp-100 -119.27 78.65 1.32 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.709 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.57 HD12 HG23 ' A' ' 5' ' ' THR . 1.4 pt -62.06 -39.59 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.121 -0.49 . . . . 0.0 112.257 -179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.57 HG23 HD12 ' A' ' 4' ' ' ILE . 29.0 p -102.72 -59.19 1.75 Allowed 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.311 0.577 . . . . 0.0 111.11 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.3 76.55 0.23 Allowed Glycine 0 C--N 1.316 -0.532 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.471 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 97.3 m -84.85 -48.2 9.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.255 0.55 . . . . 0.0 111.107 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' SG ' ' HG2' ' A' ' 21' ' ' PRO . 10.6 m -72.47 113.13 18.25 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.359 -178.001 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -74.01 -178.45 3.87 Favored 'Trans proline' 0 C--N 1.354 0.836 0 C-N-CA 121.823 1.682 . . . . 0.0 113.164 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 70.1 m -53.77 -45.14 70.54 Favored 'General case' 0 CA--C 1.504 -0.795 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.979 177.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 15' ' ' ASP . . . -48.41 -34.72 14.01 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 114.743 -1.117 . . . . 0.0 111.074 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 2.3 m -72.66 -34.91 67.57 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 121.197 -0.201 . . . . 0.0 110.747 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.36 -45.28 80.66 Favored 'General case' 0 CA--C 1.508 -0.646 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.87 -75.14 1.17 Allowed Glycine 0 C--N 1.316 -0.548 0 C-N-CA 119.796 -1.192 . . . . 0.0 112.41 176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.463 ' N ' ' O ' ' A' ' 11' ' ' GLY . 13.1 m-20 -84.01 103.7 13.47 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.678 0.752 . . . . 0.0 110.506 179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.9 t -77.25 78.59 3.77 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.803 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.439 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.0 p90 -72.8 159.15 86.03 Favored Pre-proline 0 N--CA 1.446 -0.65 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.097 178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.46 -42.54 60.63 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.654 2.236 . . . . 0.0 115.092 -177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -73.73 -3.46 28.55 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 119.582 -0.847 . . . . 0.0 112.418 -177.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 45.5 m -67.09 122.69 83.81 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 119.464 -0.895 . . . . 0.0 109.251 178.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.515 ' HG2' ' SG ' ' A' ' 8' ' ' CYS . 94.1 Cg_exo -46.73 163.94 0.11 Allowed 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 121.864 1.709 . . . . 0.0 112.893 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.8 139.92 49.32 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.8 2.334 . . . . 0.0 112.533 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 59.59 14.2 27.39 Favored Glycine 0 C--N 1.318 -0.442 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.523 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.79 -40.81 18.29 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.694 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 29.8 p -88.93 147.04 24.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 120.979 0.419 . . . . 0.0 110.981 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.56 61.23 5.5 Favored Glycine 0 CA--C 1.505 -0.537 0 C-N-CA 120.422 -0.894 . . . . 0.0 112.395 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.72 94.08 3.95 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.644 0.735 . . . . 0.0 110.575 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 79.3 t 46.8 90.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 114.622 -1.172 . . . . 0.0 111.496 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -136.26 105.0 5.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.632 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 mt -141.88 -77.97 0.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.074 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 11.8 t30 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.915 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.566 -0.214 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -120.58 37.64 4.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.905 0.383 . . . . 0.0 110.756 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -152.23 144.6 24.03 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 7' ' ' THR . 8.2 tp -53.55 154.19 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.685 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.45 -17.77 6.92 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.401 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.23 -77.9 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.105 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.487 ' O ' HD11 ' A' ' 4' ' ' ILE . 81.4 m -155.55 -87.14 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.472 ' SG ' ' HD2' ' A' ' 21' ' ' PRO . 31.9 m -72.31 114.9 33.66 Favored Pre-proline 0 N--CA 1.45 -0.473 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.7 -177.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -75.0 -179.69 5.24 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 121.844 1.696 . . . . 0.0 113.113 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 35.5 m -53.79 -45.4 70.7 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 114.748 -1.115 . . . . 0.0 111.182 177.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' O ' ' A' ' 15' ' ' ASP . . . -48.24 -33.93 11.86 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 114.64 -1.164 . . . . 0.0 111.044 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.499 ' O ' ' CB ' ' A' ' 25' ' ' CYS . 2.3 m -72.98 -35.17 66.82 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 121.311 -0.155 . . . . 0.0 110.82 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.566 ' O ' HD12 ' A' ' 30' ' ' LEU . 2.1 m -66.19 -46.53 76.98 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -82.33 -74.37 1.18 Allowed Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 119.85 -1.166 . . . . 0.0 112.366 176.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.487 ' O ' ' O ' ' A' ' 11' ' ' GLY . 41.0 m-20 -83.71 103.44 13.01 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.755 0.788 . . . . 0.0 110.378 179.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.47 78.24 3.98 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 114.868 -1.06 . . . . 0.0 111.581 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CZ ' ' SG ' ' A' ' 12' ' ' CYS . 7.3 p90 -72.86 159.15 86.01 Favored Pre-proline 0 N--CA 1.448 -0.547 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.374 178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -52.85 -42.61 62.46 Favored 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 122.727 2.284 . . . . 0.0 115.025 -177.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -73.86 -2.67 24.72 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 119.827 -0.749 . . . . 0.0 112.435 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' SG ' ' CE2' ' A' ' 17' ' ' TYR . 33.2 m -66.83 122.38 82.07 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 119.42 -0.912 . . . . 0.0 109.984 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.778 ' O ' ' HB2' ' A' ' 24' ' ' CYS . 83.6 Cg_exo -50.28 139.92 35.02 Favored 'Trans proline' 0 C--N 1.354 0.847 0 C-N-CA 121.909 1.739 . . . . 0.0 113.131 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -43.94 140.09 5.25 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.01 2.473 . . . . 0.0 114.276 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 61.45 14.36 41.43 Favored Glycine 0 N--CA 1.465 0.583 0 CA-C-N 114.523 -1.217 . . . . 0.0 113.667 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.778 ' HB2' ' O ' ' A' ' 21' ' ' PRO . 0.7 OUTLIER -84.11 -39.98 18.83 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.67 -0.412 . . . . 0.0 110.862 178.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.499 ' CB ' ' O ' ' A' ' 12' ' ' CYS . 27.9 p -89.53 149.75 22.75 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.067 0.461 . . . . 0.0 111.881 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.67 69.05 1.44 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.267 179.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.754 ' HG2' HG23 ' A' ' 28' ' ' VAL . 18.7 pm0 -118.44 -24.36 6.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.834 0.35 . . . . 0.0 111.412 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.754 HG23 ' HG2' ' A' ' 27' ' ' GLN . 23.1 t -149.99 89.7 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.009 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.6 t-20 58.53 91.53 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.848 0.356 . . . . 0.0 111.019 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.566 HD12 ' O ' ' A' ' 13' ' ' SER . 3.1 tp -83.46 -59.38 2.47 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.047 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.184 -0.913 . . . . 0.0 110.926 -179.909 . . . . . . . . 0 0 . 1 stop_ save_